Anat Naschitz is a Managing Director at OrbiMed. OrbiMed is the world’s largest healthcare investment firm with over $15 billion under management across public and private asset classes. The firm covers the entire healthcare spectrum, investing in biopharmaceuticals, medical devices and digital health. Anat has over 20 years of healthcare experience, and has a particular interest in digital health. She currently serves on the boards of digital health, biotech and medical device companies.
Prior experience includes seven years with McKinsey & Company in London, where Anat was an Associate Partner, managing strategy and M&A projects for senior management of the world’s preeminent pharmaceutical and biotechnology companies. Among other accomplishments, Anat led pharmaceutical spinout work resulting in the creation of two European biotech companies, one of which currently trades at >$3bn.
Post McKinsey Anat joined Apax Partners, where she focused on life sciences investments. Subsequently Anat served as a director/advisor to the boards of life science companies and investors. She earned her M.B.A. at INSEAD and her LL.B. at Tel Aviv University.